Possibly driven partly by BMI, snoring and sleep apnea were associated with increased risk for hypertension and CAD, according to a Mendelian randomization analysis. “Our results suggested sleep ...

Key takeaways: Those without obesity faced a high risk for major cardiovascular events after acute coronary syndrome due to obstructive sleep apnea. Researchers recommend sleep apnea screening in ...

A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with ...

An implantable, FDA-approved device for obstructive sleep apnea — designed to replace a CPAP — works best for people who aren’t too overweight, a new study finds.

Injections of tirzepatide (called Zepbound in the US) used for weight management and obesity may also reduce the severity of sleep apnea in those who have the condition, according to a summary of ...

Inspire is typically indicated for adults over 18 years old with moderate to severe sleep apnea and a body mass index of 32 or lower. Sepulveda says he also tends to lean toward more conservative ...

A total of 12,287 people were included in the study, with the average participant aged 50 years and overweight with a body mass index (BMI) of 28 kg/m 2. Nearly 90% of the participants were male.

To qualify for the device, called a hypoglossal nerve stimulator, a person over 18 diagnosed with moderate-to-severe obstructive sleep apnea must be unable to adapt or refuse to wear a continuous ...